EPL Q1FY27: Revenue up 25% YoY, but consolidated PAT flat as margins compress
PAT -0.8% YoY · revenue +25.3% · margins compressing
₹1,387.9 Cr
+25.3% YoY
₹100.6 Cr
-0.8% YoY
7.23%
-1.9pp YoY
₹3.08
EPL's consolidated revenue for the quarter ended June 30, 2026 came in at ₹1,387.9 Cr, up 25.3% YoY from ₹1,107.9 Cr and up 6.7% QoQ from ₹1,300.5 Cr — growth well ahead of management's reiterated long-term guidance of 11-13% revenue growth. But consolidated PAT of ₹100.6 Cr was essentially flat, down 0.8% YoY from ₹101.4 Cr and down 2.6% QoQ from ₹103.3 Cr, so the strong top line did not flow through to the bottom line. Basic EPS was ₹3.08 versus ₹3.13 a year ago and ₹3.22 last quarter. Standalone (India-led) numbers were far smaller — revenue ₹400.3 Cr and PAT ₹22.0 Cr — underscoring how much of the group's scale now sits offshore.
Q1 FY-2027 vs prior quarters
The disconnect between revenue and profit traces to two places. First, margins compressed: operating margin fell to 19.01% from 20.49% a year ago (19.71% last quarter), and net profit margin fell to 7.23% from 9.09% YoY, as cost of materials consumed grew 27.7% YoY to ₹611.1 Cr — faster than revenue — alongside a 24.6% YoY rise in employee costs to ₹279.7 Cr. Second, and more decisively, tax expense nearly doubled to ₹28.3 Cr from ₹15.9 Cr YoY, pushing the effective tax rate to 21.9% from 13.6% a year ago (10.6% last quarter). Pre-tax profit (PBT) actually grew a healthy 9.9% YoY to ₹128.9 Cr, so the higher tax bill — not weak operations alone — is what erased the quarter's profit growth.
The stock went into the print at ₹235.78, down 0.4% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
No exceptional items this quarter (clean YoY base) — Q4 FY26 alone had ₹16.2 Cr of exceptional charges from New Labour Codes and Indovida merger costs
Management reiterates its long-term guidance of 11-13% revenue growth, with EBITDA growth expected to be slightly higher. Despite near-term volatility from the Middle East crisis, the company is confident in its ability to fully pass through all cost increases without a lag, thereby protecting absolute EBITDA. Strategi
— This quarter: missed
Management's May 2026 guidance was to grow EBITDA 'slightly higher' than revenue by fully passing through cost increases without a lag. On revenue the company beat its own long-term target by a wide margin; on the EBITDA-protection promise it fell short — operating margin compressed rather than held. Segment-wise, growth was broad: EAP (China/Philippines/Thailand) led at +34% YoY to ₹360.2 Cr, AMERICAS grew 29% to ₹379.2 Cr, Europe 20% to ₹321.4 Cr, and AMESA (India/Egypt) 17% to ₹437.4 Cr — the EAP strength lines up with management's stated push to scale Thailand, where the company invested a further ₹14.45 Cr (144.54 million Thai Baht) into its subsidiary on July 4, 2026. During the quarter EPL also received CCI approval (May 27, 2026) for the Indovida India merger, which remains pending further statutory approvals and is not yet reflected in these numbers, and issued ₹60 Cr of commercial paper on two separate occasions (July 27 and July 29) as part of its ongoing short-term funding program. No management press release accompanying this result was available for this analysis, and no street/consensus estimates specific to this quarter could be sourced, so the print cannot be benchmarked against analyst expectations here.
W1
Effective tax rate spiked to 21.9% this quarter from a ~13-14% run-rate — watch if it normalises, since a repeat keeps profit growth trailing revenue
W2
Operating margin has now compressed for two straight quarters (20.49% → 19.71% → 19.01%) — watch if management's committed full cost pass-through shows up in H2 FY27
W3
Indovida India merger has CCI approval (May 27, 2026) but remains subject to further statutory approvals against management's ~12-month completion target set in the Q4 FY26 call
Both statements reported in Rs. Million (converted /10 to Cr); consolidated PBT of Rs128.9 Cr includes Rs2.6 Cr share of profit from associate on top of Rs126.3 Cr pre-associate EBIT; consolidated PAT Rs100.6 Cr includes Rs2.0 Cr non-controlling interest (owners' share Rs98.6 Cr, used for EPS). No exceptional items this quarter or year-ago quarter (Q4FY26 alone carried Rs16.2 Cr exceptional charges), so YoY is a clean comparison.
Informational and educational content only. Not investment advice.